Novanta Balance Sheet Health
Financial Health criteria checks 3/6
Novanta has a total shareholder equity of $742.2M and total debt of $457.5M, which brings its debt-to-equity ratio to 61.6%. Its total assets and total liabilities are $1.4B and $676.6M respectively. Novanta's EBIT is $111.7M making its interest coverage ratio 3.7. It has cash and short-term investments of $92.7M.
Key information
61.6%
Debt to equity ratio
US$457.52m
Debt
| Interest coverage ratio | 3.7x |
| Cash | US$92.69m |
| Equity | US$742.20m |
| Total liabilities | US$676.63m |
| Total assets | US$1.42b |
Recent financial health updates
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
May 30
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
Feb 05Recent updates
Novanta Inc.'s (NASDAQ:NOVT) Business Is Yet to Catch Up With Its Share Price
Dec 21Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital
Oct 15What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S
Sep 12Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold
Sep 02Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?
Aug 24Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price
Aug 02Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively
Jun 22Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
May 30Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)
May 08Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger
Feb 24Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
Feb 05Novanta Non-GAAP EPS of $0.78 beats by $0.06, revenue of $215.34M beats by $6.27M, raises FY guidance
Aug 09Financial Position Analysis
Short Term Liabilities: NOVT's short term assets ($436.9M) exceed its short term liabilities ($156.6M).
Long Term Liabilities: NOVT's short term assets ($436.9M) do not cover its long term liabilities ($520.0M).
Debt to Equity History and Analysis
Debt Level: NOVT's net debt to equity ratio (49.2%) is considered high.
Reducing Debt: NOVT's debt to equity ratio has increased from 56.5% to 61.6% over the past 5 years.
Debt Coverage: NOVT's debt is well covered by operating cash flow (29.7%).
Interest Coverage: NOVT's interest payments on its debt are well covered by EBIT (3.7x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 01:29 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/27 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Novanta Inc. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Mason | Baird |
| Ishan Majumdar | Baptista Research |
| Andrew Buscaglia | Berenberg |